The Bridge Project is a unique, inter-institutional, collaborative cancer research program between MIT’s Koch Institute for Integrative Cancer Research (KI) and  Dana-Farber/Harvard Cancer Center (DF/HCC). By uniting engineering, advanced cancer biology, and clinical oncology, the Bridge Project has created a new research model that formally strengthens interactions in translational cancer research to tackle today’s most challenging problems in diagnostics, drug delivery and resistance, and durable treatment response. The Bridge Project is supported entirely by philanthropic gifts from individuals and foundations, raised jointly by the KI and DF/HCC.

In 2015, the Commonwealth Foundation for Cancer Research made a five-year, $20M challenge grant to the Bridge Project, with the dual goal of driving research to the clinic and inspiring other donors to support this extraordinary effort.